T2D: Don’t Sugar Coat It

The Role of Endogenous GLP-1

Episode Summary

Join multidisciplinary experts in T2D: Dr John Anderson, Dr Vivian Fonseca, and Dr Jim Gavin as they discuss the fascinating history of GLP-1 discovery and the role of endogenous GLP-1 in the pathophysiology of T2D. This podcast is sponsored by Novo Nordisk and is intended for Healthcare Practitioners.

Episode Notes

What is the role of endogenous GLP-1 in the pathophysiology of T2D? Join multidisciplinary experts in T2D: Dr John Anderson, Dr Vivian Fonseca, and Dr Jim Gavin as they discuss the fascinating history of GLP-1 discovery and the role of endogenous GLP-1 in the pathophysiology of T2D.

This podcast is sponsored by Novo Nordisk and is intended for Healthcare Practitioners.

Faculty Presenters:

John E. Anderson, MD
Internal Medicine and Diabetes
The Frist Clinic
Nashville, Tennessee

James R. Gavin III, MD, PhD
Clinical Professor of Medicine, Emory University
Chief Medical Officer, Healing Our Village, Inc.
Atlanta, Georgia

Vivian A. Fonseca, MD, FRCP
Professor of Medicine, Assistant Dean for Research
Tulane University
New Orleans, Louisiana